Impact of adherence to long-term oxygen therapy on patients with COPD and exertional hypoxemia followed for one year

Carolina Bonfanti Mesquita, Caroline Knaut, Laura Miranda de Oliveira Caram, Renata Ferrari, Silmeia Garcia Zanati Bazan, Irma Godoy, Suzana Erico Tanni, Carolina Bonfanti Mesquita, Caroline Knaut, Laura Miranda de Oliveira Caram, Renata Ferrari, Silmeia Garcia Zanati Bazan, Irma Godoy, Suzana Erico Tanni

Abstract

Objective: To determine the impact of adherence to long-term oxygen therapy (LTOT) on quality of life, dyspnea, and exercise capacity in patients with COPD and exertional hypoxemia followed for one year.

Methods: Patients experiencing severe hypoxemia during a six-minute walk test (6MWT) performed while breathing room air but not at rest were included in the study. At baseline and after one year of follow-up, all patients were assessed for comorbidities, body composition, SpO2, and dyspnea, as well as for anxiety and depression, having also undergone spirometry, arterial blood gas analysis, and the 6MWT with supplemental oxygen. The Saint George's Respiratory Questionnaire (SGRQ) was used in order to assess quality of life, and the Body mass index, airflow Obstruction, Dyspnea, and Exercise capacity (BODE) index was calculated. The frequency of exacerbations and the mortality rate were noted. Treatment nonadherence was defined as LTOT use for < 12 h per day or no LTOT use during exercise.

Results: A total of 60 patients with COPD and exertional hypoxemia were included in the study. Of those, 10 died and 11 experienced severe hypoxemia during follow-up, 39 patients therefore being included in the final analysis. Of those, only 18 (46.1%) were adherent to LTOT, showing better SGRQ scores, higher SpO2 values, and lower PaCO2 values than did nonadherent patients. In all patients, SaO2, the six-minute walk distance, and the BODE index worsened after one year. There were no differences between the proportions of adherence to LTOT at 3 and 12 months of follow-up.

Conclusions: Quality of life appears to be lower in patients with COPD and exertional hypoxemia who do not adhere to LTOT than in those who do. In addition, LTOT appears to have a beneficial effect on COPD symptoms (as assessed by SGRQ scores). (Brazilian Registry of Clinical Trials - ReBEC; identification number RBR-9b4v63 [http://www.ensaiosclinicos.gov.br]).

Figures

Figure 1. Flow chart of inclusion and…
Figure 1. Flow chart of inclusion and exclusion of patients. LTOT: long-term oxygen therapy.
Figure 2. Saint George’s Respiratory Questionnaire (SGRQ)…
Figure 2. Saint George’s Respiratory Questionnaire (SGRQ) domain scores for adherent and nonadherent patients at baseline and after one year of follow-up. p

References

    1. Costa CH, Rufino R, Lapa E Silva JR. Células inflamatórias e seus mediadores na patogênese da DPOC. Rev Assoc Med Bras (1992) 2009;55(3):347–354. doi: 10.1590/S0104-42302009000300031.
    1. Global Initiative for Chronic Obstructive Lung Disease . Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary, updated 2015. Bethesda: GOLD; 2015.
    1. Coleta KD, Lima DF, Tanni SE, Silveira LV, Godoy I, Godoy I. Gender and health status response to long-term oxygen therapy in COPD patients [Article in Spanish] Arch. Bronconeumol. 2011;47(8):382–388. doi: 10.1016/j.arbres.2011.03.009.
    1. Nocturnal Oxygen Therapy Trial Group Continuous or nocturnal oxygen therapy in hypoxemic chronic obstructive lung disease a clinical trial. Ann Intern Med. 1980;93(3):391–398. doi: 10.7326/0003-4819-93-3-391.
    1. Medical Research Council Working Party Long term domiciliary oxygen therapy in chronic hypoxic cor pulmonale complicating chronic bronchitis and emphysema Report of the Medical Research Council Working Party. Lancet. 1981;1(8222):681–686.
    1. Drummond MB, Blackford AL, Benditt JO, Make BJ, Sciurba FC, McCormack MC. Continuous oxygen use in nonhypoxemic emphysema patients identifies a high-risk subset of patients retrospective analysis of the National Emphysema Treatment Trial. Chest. 2008;134(3):497–506. doi: 10.1378/chest.08-0117.
    1. Eaton T, Garret JE, Young P, Fergusson W, Kolbe J, Rudkin S, Whyte K. Ambulatory oxygen improves quality of life of COPD patients a randomised controlled study. Eur Respir J. 2002;20(2):306–312. doi: 10.1183/09031936.02.00301002.
    1. Garrod R, Mikelsons C, Paul EA, Wedzicha JA. Randomized controlled trial of domiciliary noninvasive positive pressure ventilation and physical training in severe chronic obstructive pulmonary disease. Pt 1Am J Respir Crit Care Med. 2000;162(4):1335–1341. doi: 10.1164/ajrccm.162.4.9912029.
    1. Wadell K, Henriksson-Larsén K, Lundgren R. Physical training with and without oxygen in patients with chronic obstructive pulmonary disease and exercise-induced hypoxaemia. J Rehabil Med. 2001;33(5):200–205. doi: 10.1080/165019701750419581.
    1. Long-Term Oxygen Treatment Trial Research Group.Albert DH.Blackford AL.Casaburi R.Cooper JA Jr A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med. 2016;375(17):1617–1627. doi: 10.1056/NEJMoa1604344.
    1. Mitrouska I, Tzanakis N, Siafakas NM. Oxygen therapy in chronic obstructive pulmonary disease. Eur Respir Mon. 2006;38:302–312. doi: 10.1183/1025448x.00038018.
    1. Fabbri LM, Luppi F, Beghé B, Rabe KF. Update in chronic obstructive pulmonary disease 2005. Am J Respir Crit Care Med. 2006;173(10):1056–1065. doi: 10.1164/rccm.2603005.
    1. Hardinge M, Suntharalingam J, Wilkinson T. British Thoracic Society Guideline update The British Thoracic Society Guidelines on home oxygen use in adults. Thorax. 2015;70(6):589–591. doi: 10.1136/thoraxjnl-2015-206918.
    1. American Thoracic Society Standardization of spirometry--1987 update Statement of the American Thoracic Society. Am Rev Respir Dis. 1987;136(5):1285–1298. doi: 10.1164/ajrccm/136.5.1285.
    1. Sociedade Brasileira de Pneumologia e Tisiologia II Consenso Brasileiro sobre Doença Pulmonar Obstrutiva Crônica. J Pneumol. 2004;30(Suppl 5):S1–S42.
    1. Kyle UG, Pichard C, Rochat T, Slosman DO, Fitting JW, Thiebaud D. New bioelectrical impedance formula for patients with respiratory insufficiency comparison to dual-energy X-ray absorptiometry. Eur Respir J. 1998;12(4):960–966. doi: 10.1183/09031936.98.12040960.
    1. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82(1):53–59. doi: 10.1093/ajcn/82.1.53.
    1. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS Statement guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–117. doi: 10.1164/ajrccm.166.1.at1102.
    1. Souza TC, Jardim JR, Jones P. Validação do questionário do hospital Saint George na doença respiratória (SGRQ) em pacientes portadores de doença pulmonar obstrutiva crônica no Brasil. J Pneumol. 2000;26(3):119–128. doi: 10.1590/S0102-35862000000300004.
    1. Kovelis D, Segretti NO, Probst VS, Lareau SC, Brunetto AF, Pitta F. Validation of the Modified Pulmonary Functional Status and Dyspnea Questionnaire and the Medical Research Council scale for use in Brazilian patients with chronic obstructive pulmonary disease. J Bras Pneumol. 2008;34(12):1008–1018. doi: 10.1590/S1806-37132008001200005.
    1. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurement of dyspnea Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest. 1984;85(6):751–758. doi: 10.1378/chest.85.6.751.
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;67(6):361–370. doi: 10.1111/j.1600-0447.1983.tb09716.x.
    1. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245–1251. doi: 10.1016/0895-4356(94)90129-5.
    1. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, Mendez RA, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(10):1005–1012. doi: 10.1056/NEJMoa021322.
    1. O'Neill B, Bradley JM, Heaney L, O'Neill C, MacMahon J. Short burst oxygen therapy in chronic obstructive pulmonary disease a patient survey and cost analysis. Int J Clin Pract. 2005;59(7):751–753. doi: 10.1111/j.1368-5031.2005.00574.x.
    1. Verduri A, Ballerin L, Simoni M, Cellini M, Vagnoni E, Roversi P. Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals. Intern Emerg Med. 2014;9(3):319–324. doi: 10.1007/s11739-012-0898-2.
    1. Earnest MA. Explaining adherence to supplemental oxygen therapy. J Gen Intern Med. 2002;17(10):749–755. doi: 10.1046/j.1525-1497.2002.20218.x.
    1. Chaney JC, Jones K, Grathwohl K, Olivier KN. Implementation of an oxygen therapy clinic to manage users of long-term oxygen therapy. Chest. 2002;122(5):1661–1667. doi: 10.1378/chest.122.5.1661.
    1. Cano NJ, Pichard C, Roth H, Court-Fortuné I, Cynober L, Gérard-Boncompain M. C-reactive protein and body mass index predict outcome in end-stage respiratoryfailure. Chest. 2004;126(2):540–546. doi: 10.1378/chest.126.2.540.
    1. Rooyackers JM, Dekhuijzen PN, Van Herwaarden CL, Folgering HT. Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise. Eur Respir J. 1997;10(6):1278–1284. doi: 10.1183/09031936.97.10061278.
    1. Morakami FK, Morita AA, Bisca GW, Felcar JM, Ribeiro M, Furlanetto KC, et al. Can the six-minute walk distance predict the occurrence of acute exacerbations of COPD in patients in Brazil. J Bras Pneumol. 2017;43(4):280–284. doi: 10.1590/S1806-37562016000000197.
    1. Ferrari R, Tanni SE, Lucheta PA, Faganello MM, do Amaral RA, Godoy I. Gender differences in predictors of health status in patients with COPD. J Bras Pneumol. 2010;36(1):37–43. doi: 10.1590/S1806-37132010000100008.
    1. Emtner M, Porszasz J, Burns M, Somfay A, Casaburi R. Benefits of supplemental oxygen in exercise training in nonhypoxemic chronic pulmonary disease patients. Am J Respir Crit Care Med. 2003;168(9):1034–1042. doi: 10.1164/rccm.200212-1525OC.
    1. Takigawa N, Tada A, Soda R, Date H, Yamashita M, Endo S. Distance and oxygen desaturation in 6-min walk test predict prognosis in COPD patients. Respir Med. 2007;101(3):561–567. doi: 10.1016/j.rmed.2006.06.017.
    1. Casanova C, Cote C, Marin JM, Pinto-Plata V, de Torres JP, Aguirre-Jaíme A. Distance and oxygen desaturation during the 6-min walk test as predictors of long-term mortality in patients with COPD. Chest. 2008;134(4):746–752. doi: 10.1378/chest.08-0520.
    1. Rubin AS, Souza FJ, Hetzel JL, Moreira Jda S. Immediate bronchodilator response to formoterol in poorly reversible chronic obstructive pulmonary disease. J Bras Pneumol. 2008;34(6):373–379. doi: 10.1590/S1806-37132008000600007.
    1. Figueiredo AB, Silva SR, Filho, Lôbo RR, Moriguti JC. Exacerbação da doença pulmonar obstrutiva crônica. Medicina (Ribeirão Preto) 2010;43(3):223–230. doi: 10.11606/issn.2176-7262.v43i3p223-230.
    1. Marino DM, Marrara KT, Arcuri JF, Candolo C, Jamami M, Di Lorenzo VA. Determination of exacerbation predictors in patients with COPD in physical therapy - a longitudinal study. Braz J Phys Ther. 2014;18(2):127–136. doi: 10.1590/S1413-35552012005000146.
    1. Coleta KD, Silveira LV, Lima DF, Rampinelli EA, Godoy I, Godoy I. Predictors of first-year survival in patients with advanced COPD treated using long-term oxygen therapy. Respir Med. 2008;102(4):512–518. doi: 10.1016/j.rmed.2007.12.003.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe